中国石化新闻网讯 据TradeArabia网德克萨斯州1月23日消息 埃克森美孚和可再生能源集团(REG)今天表示,它们已与科莱恩签署了一项联合研究协议,以评估从农业废弃物和残留物等来源生产生物燃料的纤维素糖的潜在用途。生物燃料有可能在减少温室气体排放方面发挥作用。 新的合作伙伴关系扩大了埃克森美孚和REG之前宣布的一项联合研究协议。在该协议中,两家公司成功地验证了REG生命科学生物转化技术的能力,该技术可以通过单一步骤将糖从纤维素生物质转化为生物柴油。 根据与科莱恩的新协议,埃克森美孚和REG可以进一步优化REG的生物转化过程,使用科莱恩之前通过sunliquid工艺生产的经过测试和基准测试的纤维素糖。两家公司的最终目标是将科莱恩和REG的工艺结合成一种无缝纤维生物质的生物柴油技术。 科莱恩的sunliquid工艺特点是无化学预处理,原料和工艺专用酶的一体化生产,从而产生高产的可发酵C5和C6糖。科莱恩将在其位于德国Straubing的商业化前工厂进行试验,使用不同类型的纤维素原料,这些原料将被转化为糖,由REG和埃克森美孚转化为高质量的低碳生物柴油。 科莱恩执行委员会成员Christian Kohlpaintner表示:“作为科莱恩战略的主要支柱,我们致力于创新和研发,同时注重可持续发展。” REG生命科学技术已证明其广泛的适用性,其工业范围从香精香料,特种化学品和运输燃料。通过与埃克森美孚的合作,REG开发了一项专有技术,利用工业微生物在一步发酵过程中将复杂的纤维素糖转化为低碳生物柴油。 吴慧丹 摘译自 TradeArabia 原文如下: ExxonMobil, REG partner with Clariant on biofuel research ExxonMobil and Renewable Energy Group (REG) said today that they have signed a joint research agreement with Clariant to evaluate the potential use of cellulosic sugars from sources such as agricultural waste and residues to produce biofuel, which has the potential to play a role in reducing greenhouse gas emissions. The new partnership expands a previously announced agreement for joint research between ExxonMobil and REG, in which the companies successfully validated the ability of REG Life Sciences bio-conversion technology to convert sugars from cellulosic biomass into biodiesel through a single-step process. The new agreement with Clariant allows ExxonMobil and REG to further optimise REG’s bio-conversion process using previously tested and benchmarked cellulosic sugars created through Clariant’s sunliquid process. The companies’ ultimate objective is to combine Clariant’s and REG’s processes into a seamless cellulosic biomass-to-biodiesel technology. Clariant’s sunliquid process features chemical-free pretreatment, the integrated production of feedstock and process-specific enzymes and thus high yields of fermentable C5 and C6 sugars. Clariant will conduct trials at its pre-commercial plant in Straubing, Germany using different types of cellulosic feedstock that will be converted into sugars for conversion by REG and ExxonMobil into high-quality, low-carbon biodiesel. “We are committed to innovation and R&D, together with a focus on sustainability, as main pillars of Clariant’s strategy,” said Christian Kohlpaintner, member of Clariant’s executive committee. REG Life Sciences technology has proven its broad applicability to industries as diverse as flavor and fragrance, specialty chemicals and transportation fuels. Through its partnership with ExxonMobil, REG has developed proprietary technology that utilizes industrial microbes to convert complex cellulosic sugars into low-carbon biodiesel in a one-step fermentation process.
未经允许,不得转载本站任何文章: